Improved Potency and Selectivity of an Oncolytic E1ACR2 and E1B19K Deleted Adenoviral Mutant in Prostate and Pancreatic Cancers
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-09-1960
Full Text
Open PDFAbstract
Available in full text
Date
January 12, 2010
Authors
Publisher
American Association for Cancer Research (AACR)